Saroja Jayakar, MD
Cardiovascular Disease · Saint Clair Shores, MINPI 1144259995
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $497 of the $577 with a category attached, or 86.1%. It is spread thinly across 16 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $289 and has fallen 82.4% since, to $51 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in MI, where the typical reported total is $2,775.
Across 29 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$138
- GSK$116
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$52
- Otsuka America Pharmaceutical, Inc.$42
- AstraZeneca$30
- Lilly USA, LLC$29
- plus $171 from 10 others
What the payments were for
- Food & beverage$49786%
- Education$8014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 3 | $138 |
| GSK | 6 | $116 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| AstraZeneca | 2 | $30 |
| Lilly USA, LLC | 2 | $29 |
| Exact Sciences | 2 | $28 |
| AbbVie | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $15 |
| Pfizer | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $13 |
| Abbott | 1 | $12 |
How this compares
$577 in reported general payments places this provider in the 25th percentile of 760 cardiovascular disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Saint Clair Shores
- Marschall RungeAnn Arbor$1.8M
- Jihad MustaphaGrand Rapids$1.6M
- Vallerie McLaughlinAnn Arbor$947K
- Pedro Villablanca SpinettoDetroit$620K
- Stanley ChetcutiAnn Arbor$573K
- David HainesRoyal Oak$492K
- Steven AlmanyTroy$471K
- David StroblLansing$445K
- Herman KadoSouthfield$442K
- Douglas HorstmanshofRoyal Oak$407K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.